Effect of Sprinkles With and w/o Fe on Zn Absorption in Kenyan Toddlers

NCT ID: NCT02101723

Last Updated: 2018-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

63 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-04-30

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators propose to study the effects of increased iron intake by home fortification of complementary foods on the gastrointestinal microbial development, inflammatory responses, and zinc (Zn) absorption. The proposed subjects are 9 month olds living in a malaria endemic area of rural Kenya who are randomized at 6 months of age to one of three fortificant groups: 1) Sprinkles™ with 12mg Iron(Fe)/day + other micronutrients, including 5mg/d Zn (test); Sprinkles™ with 0 mg/d Fe + other micronutrients, including 5mg/d Zn (control); Sprinkles™ with no micronutrients (placebo). The investigators hypothesize that the microbiome will be significantly different in the three groups and that Zn absorption and status, in addition to immune and oxidant status will be improved in the non-Fe fortified groups when compared to the Fe-fortified group.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Specific aims include exploration of possible mechanisms of adverse events that have been observed in iron supplementation trials in infants in malaria endemic regions by:

1. Characterizing the impact of enteral iron administration on the evolution of the intestinal microbiome in infants from 6 to 9 months of age.
2. Characterizing iron administration-associated inflammatory responses and correlate these with changes in the intestinal microbiome in infants from 6 to 9 months of age. Specifically, changes in the microbiome will be correlated with biomarkers reflecting:

1. Intestinal inflammation;
2. Systemic inflammation, bacterial translocation, and oxidant stress;
3. Iron status and homeostasis
3. Quantify to what degree Fe interferes with Zn absorption (TAZ) and how it affects the size of the infant's exchangeable zinc pool (EZP).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Micronutrient Deficiencies

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Micronutrient Powder (MNP) + Zn/Fe

Micronutrient Powder with 5 mg Zn and 12 mg Fe

Group Type ACTIVE_COMPARATOR

MNP + Zn/Fe

Intervention Type DIETARY_SUPPLEMENT

Micronutrient powder with 12 mg Fe and 5 mg Zn provided daily from 6-9 months of age

MNP + Zn

Micronutrient Powder with 5 mg Zn

Group Type ACTIVE_COMPARATOR

MNP + Zn

Intervention Type DIETARY_SUPPLEMENT

Micronutrient powder with 5 mg Zn provided daily from 6-9 months of age

Control

Placebo sachets without micronutrients

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo powder without micronutrients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MNP + Zn/Fe

Micronutrient powder with 12 mg Fe and 5 mg Zn provided daily from 6-9 months of age

Intervention Type DIETARY_SUPPLEMENT

MNP + Zn

Micronutrient powder with 5 mg Zn provided daily from 6-9 months of age

Intervention Type DIETARY_SUPPLEMENT

Placebo

Placebo powder without micronutrients

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Term infant
* Birthweight \> 2500 g
* Healthy with no apparent congenital anomalies
* Up-to-date with vaccinations
* Hb \>10 g/dL
* Breastfeeding with intent to continue for duration of study
* Negative blood slide for malaria
* Written informed consent

Exclusion Criteria

* Acute malnutrition
* Current or anticipated used of infant formula or other fortified products
* Current or planned use of iron (or zinc) supplements
* Previous hospitalization for malaria within the last four weeks
* Persistent diarrhea
Minimum Eligible Age

5 Months

Maximum Eligible Age

10 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

Sponsor Role collaborator

International Atomic Energy Agency

OTHER_GOV

Sponsor Role collaborator

Moi University

OTHER

Sponsor Role collaborator

University of Colorado, Denver

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Nancy F Krebs, MD

Role: PRINCIPAL_INVESTIGATOR

University of Colorado, Denver

Fabian Esamai, MD

Role: STUDY_DIRECTOR

Moi Univeristy

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Colorado Denver

Aurora, Colorado, United States

Site Status

Moi University

Eldoret, , Kenya

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Kenya

References

Explore related publications, articles, or registry entries linked to this study.

Esamai F, Liechty E, Ikemeri J, Westcott J, Kemp J, Culbertson D, Miller LV, Hambidge KM, Krebs NF. Zinc absorption from micronutrient powder is low but is not affected by iron in Kenyan infants. Nutrients. 2014 Dec;6(12):5636-51. doi: 10.3390/nu6125636.

Reference Type BACKGROUND
PMID: 25493942 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

K24DK083772

Identifier Type: NIH

Identifier Source: secondary_id

View Link

15827

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

16933

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

11-0227

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Micronutrients and Child Health Study
NCT00623857 COMPLETED PHASE3